|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Oct―17 |
Cyclic peptides targeting the SARS-CoV-2 programmed ribosomal frameshifting RNA from a multiplexed phage display library |
Jacob A. Iannuzzelli, Rachel Bonn, Andrew Sung Hong, Abhijith Saseendran Anitha, Joseph E Wedekind, Jermaine L Jenkins, Rudi Fasan |
2 |
[GO] |
2024―Aug―23 |
Water-Glycan Interactions Drive the SARS-CoV-2 Spike Dynamics: Insights into Glycan-Gate Control and Camouflage Mechanism. |
Marharyta Blazhynska, Louis Lagardere, Chengwen Liu, Olivier Adjoua, Pengyu Ren, Jean-Philip Piquemal |
3 |
[GO] |
2024―Jun―03 |
Mechanistic insights into bismuth(iii) inhibition of SARS-CoV-2 helicase |
Xueying Wei, Chun-Lung Chan, Ying Zhou, Kaiming Tang, Jingxin Chen, Suyu Wang, et al. (+4) Jasper Fuk-Woo Chan, Shuofeng Yuan, Hongyan Li, Hongzhe Sun |
4 |
[GO] |
2024―Apr―16 |
Thiophene-fused γ-lactams inhibit the SARS-CoV-2 main protease via reversible covalent acylation |
Gayatri Gayatri, Lennart Brewitz, Lewis Ibbotson, Eidarus Saleh, Shyam Basak, Hani Choudhry, Christopher J Schofield |
5 |
[GO] |
2023―Sep―18 |
Metal-coding assisted serological multi-omics profiling deciphers the role of selenium in COVID-19 immunity |
Ying Zhou, Shuofeng Yuan, Fan Xiao, Hongyan Li, Ziwei Ye, Tianfan Cheng, et al. (+14) Cuiting Luo, Kaiming Tang, Jianpiao Cai, Jianwen Situ, Siddharth Sridhar, Wing-Ming Chu, Anthony Raymond Tam, Hin Chu, Chi-Ming Che, Lijian Jin, Ivan Fan-Ngai Hung, Liwei Lu, Jasper Fuk-Woo Chan, Hongzhe Sun |
6 |
[GO] |
2023―Sep―11 |
Resolving a Guanine-Quadruplex Structure in the SARS-CoV-2 Genome through Circular Dichroism and Multiscale Molecular Modeling |
Luisa D'Anna, Tom Miclot, Emmanuelle Bignon, Ugo Perricone, Giampaolo Barone, Antonio Monari, Alessio Terenzi |
7 |
[GO] |
2023―Sep―05 |
Correction: Peptide epitope-imprinted polymer microarrays for selective protein recognition. Application for SARS-CoV-2 RBD protein |
Zsófia Bognár, Eszter Supala, Aysu Yarman, Xiaorong Zhang, Frank F. Bier, Frieder W. Scheller, Róbert E. Gyurcsányi |
8 |
[GO] |
2023―Jun―05 |
The ACE2 receptor accelerates but is not biochemically required for SARS-CoV-2 membrane fusion |
Marcos Cervantes, Tobin Hess, Giorgio Gianini Morbioli, Anjali Sengar, Peter Kasson |
9 |
[GO] |
2023―May―25 |
Isotope-Encoded Tetrahedral DNA for Multiple SARS-CoV-2 Variants Diagnosis |
Ziyan Li, Jing Zhou, Chaoqun Wang, Rui Liu, Jianyu Hu, Yi Lv |
10 |
[GO] |
2023―May―03 |
Diagnostics and Analysis of SARS-CoV-2: Current Status, Recent Advances, Challenges and Perspectives |
Aihua Liu, Tao Dong, Mingyang Wang, Junchong Liu, Pengxin Ma, Shuang Pang, Wanjian Liu |
11 |
[GO] |
2023―Apr―19 |
MOF/DNA luminescent sensing platform for detection of potential COVID-19 biomarker and drug |
Xinrui Wang, Gilles Clavier, Yan Zhang, Kamal Batra, Nannan Xiao, Guillaume Maurin, et al. (+3) Bin Ding, Antoine Tissot, Christian Serre |
12 |
[GO] |
2023―Apr―11 |
Unraveling the Catalytic Mechanism of SARS-CoV-2 Papain-like Protease with Allosteric Modulation of C270 Mutation Using Multiscale Computational Approaches |
Qiang Shao, Muya Xiong, Jiameng Li, Hangchen Hu, Haixia Su, Yechun Xu |
13 |
[GO] |
2023―Feb―17 |
SARS-CoV-2 Spike Proteins React with Au and Si, are Electrically Conductive and Denature at 3 × 10^8 V/m: a Surface Bonding and a Single-Protein Circuit Study. |
Essam M. Dief, Nadim Darwish |
14 |
[GO] |
2023―Feb―14 |
Impact of SARS-CoV-2 3CL Protease Mutations on Nirmatrelvir Inhibitory Efficiency. Computational Insights into Potential Resistance Mechanisms |
Carlos A. Ramos-Guzmán, Milorad Andjelkovic, Kirill Zinovjev, José Javier Ruiz-Pernía, Iñaki Tuñón |
15 |
[GO] |
2023―Jan―06 |
Azapeptide activity-based probes for the SARS-CoV-2 main protease enable visualization of inhibition in infected cells |
Roeland Vanhoutte, Marta Barniol-Xicota, Winston Chiu, Laura Vangeel, Dirk Jochmans, Steven De Jonghe, et al. (+5) hadeer Zidane, Haim Barr, Nir London, Johan Neyts, Steven H.L. Verhelst |
16 |
[GO] |
2022―Dec―13 |
Enantioselective Inhibition of the SARS-CoV-2 Main Protease with Rhenium(I) Picolinic Acid Complexes |
Seth M Cohen, Johannes Karges, Miriam Giardini, Olivier Blacque, Brendon Woodworth, Jair Siqueira-Neto |
17 |
[GO] |
2022―Aug―31 |
Distinct Core Glycan and O-Glycoform Utilization of SARS-CoV-2 Omicron Variant Spike Protein RBD Revealed by Top-Down Mass Spectrometry |
David Stephen Roberts, Morgan William Mann, Brad H. Li, Donguk Kim, Allan R. Brasier, Song Jin, Ying Ge |
18 |
[GO] |
2022―May―23 |
Point Mutations in SARS-CoV-2 Variants Induce Long-Range Dynamical Perturbations in Neutralizing Antibodies |
Dhiman Ray, Riley N Quijano, Ioan Andricioaei |
19 |
[GO] |
2022―May―02 |
Autophagy and evasion of immune system by SARS-CoV-2. Structural features of the Non-structural protein 6 from Wild Type and Omicron viral strains interacting with a model lipid bilayer |
Emmanuelle Bignon, Marco Marazzi, Stéphanie Grandemange, Antonio Monari |
20 |
[GO] |
2022―Feb―28 |
Antiviral cyclic peptides targeting the main protease of SARS-CoV-2 |
Jason Johansen-Leete, Sven Ullrich, Sarah E. Fry, Rebecca Frkic, Max J. Bedding, Anupriya Aggarwal, et al. (+14) Anneliese S. Ashhurst, Kasuni B. Ekanayake, Mithun C. Mahawaththa, Vishnu M. Sasi, Stephanie Luedtke, Daniel J. Ford, Anthony J. O'Donoghue, Toby Passioura, Mark Larance, Gottfried Otting, Stuart Turville, Colin J. Jackson, Christoph Nitsche, Richard J. Payne |
21 |
[GO] |
2022―Feb―15 |
Selective Covalent Targeting of SARS-CoV-2 Main Protease by Enantiopure Chlorofluoroacetamide |
Daiki Yamane, Satsuki Onitsuka, Suyong Re, Hikaru Isogai, Rui Hamada, Tadanari Hiramoto, et al. (+4) Eiji Kawanishi, Kenji Mizuguchi, Naoya Shindo, Akio Ojida |
22 |
[GO] |
2022―Feb―14 |
Multiplex Metal-Detection based Assay (MMDA) for COVID-19 diagnosis and identification of disease severity biomarkers |
Ying Zhou, Shuofeng Yuan, Kelvin Kai-Wang To, Xiaohan Xu, Hongyan Li, Jian-Piao Cai, et al. (+7) Cuiting Luo, Ivan Fan-Ngai Hung, Kwok-Hung Chan, Kwok-Yung Yuen, Yu-Feng Li, Jasper Chan, Hongzhe Sun |
23 |
[GO] |
2022―Feb―10 |
Computationally driven discovery of SARS-CoV-2 Mpro inhibitors: from design to experimental validation |
Léa El Khoury, Zhifeng Jing, Alberto Cuzzolin, Alessandro Deplano, Daniele Loco, Boris Sattarov, et al. (+29) Florent Hédin, Sebastian Wendeborn, Chris Ho, Dina El Ahdab, Theo Jaffrelot-Inizan, M Sturlese, Alice Sosic, Martina Volpiana, Angela Lugato, Marco Barone, Barbara Gatto, Maria Ludovica. Macchia, M Bellanda, Roberto Battistutta, Cristiano Salata, Ivan Kondratov, Rustan Iminov, Andrii Khairulin, Yaroslav Mykhalonok, Anton Pochepko, Volodymyr Chashka-Ratushnyi, Iaroslava Kos, Stefano Moro, Matthieu Montes, Pengyu Ren, Jay W. Ponder, Louis Lagardère, Jean-Philip Piquemal, Davide Sabbadin |
24 |
[GO] |
2021―Nov―25 |
Fine-tuning the Spike: Role of the nature and topology of the glycan shield in the structure and dynamics of the SARS-CoV-2 S |
Aoife Martha Harbison, Carl A Fogarty, Toan Phung, Akash Satheesan, Benjamin L. Schulz, Elisa Fadda |
25 |
[GO] |
2021―Nov―23 |
Peptide epitope-imprinted polymer microarrays for selective protein recognition. Application for SARS-CoV-2 RBD protein |
Zsófia Bognár, Eszter Supala, Aysu Yarman, Xiaorong Zhang, Frank F. Bier, Frieder Scheller, Róbert E. Gyurcsányi |
26 |
[GO] |
2021―Nov―17 |
Automated Discovery of Noncovalent Inhibitors of SARS-CoV-2 Main Protease by Consensus Deep Docking of 40 Billion Small Molecules |
Francesco Gentile, Michael Fernandez, Fuqiang Ban, Anh-Tien Ton, Hazem Mslati, Carl Perez, et al. (+8) Eric Leblanc, Jean Charle Yaacoub, James Gleave, Abraham Stern, Bill Wong, Francois Jean, Natalie C.J. Strynadka, Artem Cherkasov |
27 |
[GO] |
2021―Sep―24 |
Allosteric Inhibition of SARS-CoV-2 3CL Protease by Colloidal Bismuth Subcitrate |
Xuan Tao, Lu Zhang, Liubing Du, Ruyan Liao, Huiling Cai, Kai Lu, et al. (+9) Zhennan Zhao, Yanxuan Xie, Pei-Hui Wang, Ji-An Pan, Yuebin Zhang, Guo-Hui Li, Jun Dai, Zong-Wan Mao, Wei Xia |
28 |
[GO] |
2021―Sep―06 |
Modelling the Active SARS-CoV-2 Helicase Complex as a Basis for Structure-based Inhibitor Design |
Edina Rosta, Sarah A Harris, Nadia Elghobashi-Meinhardt, Andrei Pisliakov, Pedro J Buigues, Sam A Martino, et al. (+4) Geoff Wells, Denes Berta, Elisa Frezza, magd badaoui |
29 |
[GO] |
2021―Sep―06 |
Discovery of SARS-CoV-2 Mpro Peptide Inhibitors from Modelling Substrate and Ligand Binding |
H. T. Henry Chan, Marc Alexander Moesser, Rebecca K. Walters, Tika R Malla, Rebecca M Twidale, Tobias John, et al. (+22) Helen M. Deeks, Tristan Johnston-Wood, Victor Mikhailov, Richard Barry Sessions, William Dawson, Eidarus Saleh, Petra Lukacik, Claire Strain-Damerell, C David Owen, Takahito Nakajima, Katarzyna Swiderek, Alessio Lodola, Vicent Moliner, David Ryan Glowacki, James Spencer, Martin Austin A Walsh, Christopher J Schofield, Luigi Genovese, Deborah Karen Shoemark, Adrian John Mulholland, Fernanda Duarte, Garrett M. Morris |
30 |
[GO] |
2021―Aug―26 |
Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties |
Tim Hempel, Katarina Elez, Nadine Krüger, Lluís Raich, Jonathan H. Shrimp, Olga Danov, et al. (+7) Danny Jonigk, Armin Braun, Min Shen, Matthew D. Hall, Stefan Pöhlmann, Markus Hoffmann, Frank Noé |
31 |
[GO] |
2021―Jun―03 |
Determination of intermediate state structures in the opening pathway of SARS-CoV-2 spike using cryo-electron microscopy |
Z. Faidon Brotzakis, Thomas Lohr, Michele Vendruscolo |
32 |
[GO] |
2021―May―26 |
Translating Daily COVID-19 Screening into a Simple Glucose Test: A Proof of Concept Study |
Ran Liu, Yuansheng Hu, Ying He, Tian Lan, Jingjing Zhang |
33 |
[GO] |
2021―Apr―22 |
Correction: Multi-targeting of functional cysteines in multiple conserved SARS-CoV-2 domains by clinically safe Zn-ejectors |
Karen Sargsyan, Chien-Chu Lin, Ting Chen, Cédric Grauffel, Yi-Ping Chen, Wei-Zen Yang, et al. (+5) Jian-Jong Liang, Chun-Che Liao, Yi-Ling Lin, Hanna S. Yuan, Carmay Lim |
34 |
[GO] |
2021―Apr―15 |
Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies |
Jiahui Chen, Kaifu Gao, Rui Wang, Guowei Wei |
35 |
[GO] |
2021―Mar―02 |
Molecular Recognition of SARS-CoV-2 Spike Glycoprotein: Quantum Chemical Hot Spot and Epitope Analyses |
Chiduru Watanabe, Yoshio Okiyama, Shigenori Tanaka, Kaori Fukuzawa, Teruki Honma |
36 |
[GO] |
2021―Feb―02 |
High-Resolution Mining of SARS-CoV-2 Main Protease Conformational Space: Supercomputer-Driven Unsupervised Adaptive Sampling |
Theo Jaffrelot-Inizan, Frédéric CELERSE, Olivier Adjoua, Dina El Ahdab, Luc-Henri Jolly, Chengwen Liu, et al. (+6) Pengyu Ren, Matthieu Montes, Nathalie Lagarde, Louis Lagardère, Pierre Monmarché, Jean-Philip Piquemal |
37 |
[GO] |
2021―Jan―29 |
A Microscopic Description of SARS-CoV-2 Main Protease Inhibition with Michael Acceptors. Strategies for Improving Inhibitors Design |
Carlos A. Ramos-Guzmán, José Javier Ruiz-Pernía, Iñaki Tuñón |
38 |
[GO] |
2020―Nov―27 |
Mechanism of Inhibition of SARS-CoV-2 Mpro by N3 Peptidyl Michael Acceptor Explained by QM/MM Simulations and Design of New Derivatives with Tunable Chemical Reactivity |
Kemel Arafet, Natalia Serrano Aparicio, Alessio Lodola, Adrian John Mulholland, Florenci Vicent González, Katarzyna Świderek, Vicent Moliner |
39 |
[GO] |
2020―Nov―26 |
Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main protease |
Anna Pavlova, Diane L. Lynch, Isabella Daidone, Laura Zanetti-Polzi, Micholas Dean Smith, Chris Chipot, et al. (+13) Daniel W. Kneller, Andrey Kovalevsky, Leighton Coates, Andrei A. Golosov, Callum J. Dickson, Camilo Velez-Vega, Jose S. Duca, Josh V Vermaas, Yui Tik Pang, Atanu Acharya, Jerry M Parks, Jeremy C Smith, James Gumbart |
40 |
[GO] |
2020―Nov―13 |
Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with Camostat and Nafamostat |
Tim Hempel, Lluís Raich, Simon Olsson, Nurit P Azouz, Andrea M Klingler, Markus Hoffmann, et al. (+3) Stefan Pöhlmann, Marc E Rothenberg, Frank Noe |
41 |
[GO] |
2020―Oct―12 |
A Serological Aptamer-Assisted Proximity Ligation Assay for COVID-19 Diagnosis and Seeking Neutralizing Aptamers |
Ran Liu, Lei He, Yuansheng Hu, Zhaofeng Luo, Jingjing Zhang |
42 |
[GO] |
2020―Sep―30 |
Unveiling the molecular mechanism of SARS-CoV-2 main protease inhibition from 137 crystal structures using algebraic topology and deep learning |
Duc Nguyen, Kaifu Gao, Jiahui Chen, Rui Rui Wang, Guowei Wei |
43 |
[GO] |
2020―Sep―01 |
Multi-Targeting of Functional Cysteines in Multiple Conserved SARS-CoV-2 Domains by Clinically Safe Zn-ejectors |
Karen Sargsyan, Chien-Chu Lin, Ting Chen, Cedric Grauffel, Yi-Ping Chen, Wei-Zen Yang, et al. (+2) Hanna Yuan, Carmay Lim |
44 |
[GO] |
2020―Jun―25 |
Revealing the Molecular Mechanisms of Proteolysis of SARS-CoV-2 Mpro from QM/MM Computational Methods. |
Katarzyna Świderek, Vicent Moliner |